非急性前交叉韧带损伤患者手术必要性(ACL SNNAP):一项随机对照试验的统计分析计划
ACL SNNAP是一项实用性、多中心、优效性、平行组随机对照试验,针对有症状的非急性前交叉韧带缺损膝患者,按1:1随机分配至非手术管理(康复)或手术管理(重建),评估疗效与成本效果。主要结局为随机化后18个月的KOOS4评分,采用线性回归模型调整招募中心和基线KOOS4评分,并允许中心内相关性。本文描述了该试验临床结局统计分析的计划方法,以最小化数据驱动结果和报告偏倚的风险。
要点
- ACL SNNAP试验纳入有症状的非急性前交叉韧带缺损膝患者,1:1随机分配至康复或重建。
- 主要结局为随机化后18个月的KOOS4评分,用线性回归模型调整招募中心和基线评分。
- 次要结局包括重返活动/运动参与水平、干预相关并发症、EQ-5D-5L、KOOS全部5个分量表、ACL-QOL、重返活动期望及成本效果。
核心结论
- 本文呈现ACL SNNAP试验临床结局统计分析的计划方法,旨在最小化数据驱动结果和报告偏倚的风险。
- 任何与本文所述分析方法的偏离将在试验结果发表时完整描述并说明理由。
研究设计与样本
- ACL SNNAP是一项实用性、多中心、优效性、平行组随机对照试验,受试者为有症状的非急性前交叉韧带缺损膝患者。
- 参与者按1:1比例分配至非手术管理(康复)或手术管理(重建),目的是评估疗效和成本效果。
- 主要结局为随机化后18个月的KOOS4评分。
主要发现
- 主要结局分析将使用线性回归模型评估18个月时的KOOS4评分,调整招募中心和基线KOOS4评分,并允许中心内相关性。
- 主要结局的次要分析将采用曲线下面积(AUC)方法,使用混合模型获得的治疗估计值,纳入基线、6个月、12个月和18个月随机化后结局数据。
- 次要结局在18个月时测量,包括重返活动/运动参与水平、干预相关并发症、EQ-5D-5L问卷、KOOS问卷全部5个分量表、ACL-QOL评分、重返活动期望以及干预的成本效果。
- 缺失的主要结局数据将通过敏感性分析进行调查。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rupture of the anterior cruciate ligament (ACL) is a common injury, primarily affecting young, active individuals. Despite surgical intervention being the more common treatment for patients suffering ACL ruptures, current management is based on limited and generally low-quality evidence. We describe a statistical analysis plan (SAP) for the ACL SNNAP randomised controlled trial, which aims to investigate the necessity of surgical management in patients with ACL injuries. METHODS/DESIGN: ACL SNNAP is a pragmatic, multi-centre, superiority, parallel-group randomised controlled trial in participants with a symptomatic non-acute ACL deficient knee. Participants are allocated in a 1:1 ratio to either non-surgical management (rehabilitation) or surgical management (reconstruction) with the aim of assessing the efficacy and cost-effectiveness. The primary outcome of the study is the Knee Injury and Osteoarthritis Outcome Score (KOOS4) at 18 months post-randomisation. The KOOS4 score at 18 months will be evaluated using a linear regression model adjusting for recruitment centre and baseline KOOS4 scores, allowing for intra-centre correlation. A secondary analysis of the primary outcome will be carried out using an area under the curve (AUC) approach using treatment estimates obtained from a mixed model using baseline, 6 months, 12 months, and 18 months post-randomisation outcome data. Secondary outcomes will be measured at 18 months and will include return to activity/level of sport participation, intervention-related complications, the EQ-5D-5L questionnaire, all 5 individual subscales of the KOOS questionnaire, the ACL-QOL score, expectations of return to activity and cost-effectiveness of the interventions. Missing primary outcome data will be investigated through a sensitivity analysis. Full details of the planned methods for the statistical analysis of clinical outcomes are presented in this paper. The study protocol for the ACL SNNAP trial has been published previously. DISCUSSION: The methods of analysis for the ACL SNNAP trial have been described here to minimise the risk of data-driven results and reporting bias. Any deviations from the analysis methods described in this paper will be described in full and justified in the publications of the trial results. TRIAL REGISTRATION: ISRCTN ISRCTN10110685 . Registered on 16 November 2016.
引用
- Stokes JR, Beard DJ, Davies L, et al. ACL Surgery Necessity in Non-Acute Patients (ACL SNNAP): a statistical analysis plan for a randomised controlled trial. Trials. 2022. PMID: 35550002. doi:10.1186/s13063-022-06309-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。